CULLINAN
Cullinan Oncology, Llc
Application Filed: 2016-10-12
Trademark Application Details
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87200486 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Gwenn Roos |
| Law Office Assigned | M10 |
| Employee Name | CLYBURN, CARLA DIONNE |
Timeline
| 2016-10-12 | Application Filed |
| 2018-05-03 | Abandon |
| 2018-06-13 | Location: TMO LAW OFFICE 110 - EXAMINING ATTORNEY ASSIGNED |
| 2018-06-13 | Status: Dead/Abandoned |
| 2020-01-07 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  CULLINAN ONCOLOGY, LLC |
| Address | 450 KENDALL STREET CAMBRIDGE DE 02142 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0421 | Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of technology in the field of oncology; Research and development of vaccines and medicines; Research in the field of oncology; Research in the field of oncology; Research on the subject of pharmaceuticals; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Conducting clinical trials for others; Conducting clinical trials for others in the field of oncology; Conducting scientific research in the field of oncology at animal sanctuary facilities; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Genetic testing for scientific research purposes; Laboratory research in the field of oncology; Laboratory research services relating to pharmaceuticals; Medical research; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of oncology; Medical and scientific research information in the field of oncology; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research services in the field of cancer; Pharmaceutical research and development; Pharmaceutical research services; Product research and development; Providing a website featuring educational information in the field of clinical research; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical research and scientific research information in the field of oncology via the Internet; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical research and scientific research information in the field of oncology via the Internet; Providing medical testing services and information in the field of cancer research and disease classification; Providing medical testing services and information in the field of cancer research and disease classification; Providing scientific research information in the field of oncology; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific research; Scientific research and development; Scientific research consulting in the field of oncology; Scientific research for medical purposes in the field of oncology; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of oncology; Scientific study and research in the field(s) of oncology; Technical research in the field of pharmaceutical studies; Technology consultation and research in the field of oncology |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2016-10-15 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2016-10-17 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2017-01-17 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2017-01-18 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2017-01-18 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-01-18 | 6 GNRN O:Outgoing Correspondence |
| NON-FINAL ACTION WRITTEN | 2017-01-18 | 7 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2017-01-18 | 8 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-01-18 | 9 GNRN O:Outgoing Correspondence |
| TEAS PETITION TO REVIVE RECEIVED | 2017-08-15 | 10 PROA I:Incoming Correspondence |
| PETITION TO REVIVE-GRANTED | 2017-08-15 | 11 PETG O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2017-08-15 | 12 TROA I:Incoming Correspondence |
| NOTICE OF REVIVAL - E-MAILED | 2017-08-16 | 13 NREV E:E-Mail |
| ASSIGNED TO LIE | 2017-08-31 | 14 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-08-31 | 15 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-08-31 | 16 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-08-31 | 17 CNSA P: |
| WITHDRAWN FROM PUB - OG REVIEW QUERY | 2017-09-19 | 18 PBCR Z:Deletion |
| PREVIOUS ALLOWANCE COUNT WITHDRAWN | 2017-10-12 | 19 ZZZX Z:Deletion |
| NON-FINAL ACTION WRITTEN | 2017-11-03 | 20 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2017-11-03 | 21 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-11-03 | 22 GNRN O:Outgoing Correspondence |
| ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2018-06-13 | 23 ABN2 O:Outgoing Correspondence |
| ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | 2018-06-13 | 24 MAB2 O:Outgoing Correspondence |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2018-08-01 | 25 ASGN I:Incoming Correspondence |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 